Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr;68(4):645-660.
doi: 10.1007/s00262-018-2200-6. Epub 2018 Jul 12.

Interactions among myeloid regulatory cells in cancer

Affiliations
Review

Interactions among myeloid regulatory cells in cancer

Viktor Umansky et al. Cancer Immunol Immunother. 2019 Apr.

Abstract

Mounting evidence has accumulated on the critical role of the different myeloid cells in the regulation of the cancerous process, and in particular in the modulation of the immune reaction to cancer. Myeloid cells are a major component of host cells infiltrating tumors, interacting with each other, with tumor cells and other stromal cells, and demonstrating a prominent plasticity. We describe here various myeloid regulatory cells (MRCs) in mice and human as well as their relevant therapeutic targets. We first address the role of the monocytes and macrophages that can contribute to angiogenesis, immunosuppression and metastatic dissemination. Next, we discuss the differential role of neutrophil subsets in tumor development, enhancing the dual and sometimes contradicting role of these cells. A heterogeneous population of immature myeloid cells, MDSCs, was shown to be generated and accumulated during tumor progression as well as to be an important player in cancer-related immune suppression. Lastly, we discuss the role of myeloid DCs, which can either contribute to effective anti-tumor responses or play a more regulatory role. We believe that MRCs play a critical role in cancer-related immune regulation and suggest that future anti-cancer therapies will focus on these abundant cells.

Keywords: Dendritic cells; Macrophages; Mye-EUNITER; Myeloid regulatory cells; Myeloid-derived suppressor cells; Neutrophils.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Multiple effects and interactions among the different types of MRCs in cancer. Macrophages, M2 M2 macrophages, TAN tumor-associated neutrophils, N2 N2 TAN, Mo-MDSC monocytic myeloid-derived suppressor cells, PMN-MDSC polymorphonuclear MDSC, DC dendritic cells, Treg regulatory T cells
Fig. 2
Fig. 2
Effects of tumor cells on MRC subsets and that of MRCs on T cell subpopulations in cancer. M2 M2 macrophages, N2 N2 tumor-associated neutrophils, Mo-MDSC monocytic myeloid-derived suppressor cells, PMN-MDSC polymorphonuclear MDSC, DC dendritic cells, Treg regulatory T cells

Similar articles

Cited by

References

    1. Giraldo NA, Becht E, Remark R, Damotte D, Sautès-Fridman C, Fridman WH. The immune contexture of primary and metastatic human tumours. Curr Opin Immunol. 2014;27:8–15. doi: 10.1016/j.coi.2014.01.001. - DOI - PubMed
    1. Coulie PG, Van den Eynde BJ, van der Bruggen P, Boon T. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer. 2014;14:135–146. doi: 10.1038/nrc3670. - DOI - PubMed
    1. Bonavita E, Galdiero MR, Jaillon S, Mantovani A. Phagocytes as corrupted policemen in cancer-related inflammation. Adv Cancer Res. 2015;128:141–171. doi: 10.1016/bs.acr.2015.04.013. - DOI - PubMed
    1. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–899. doi: 10.1016/j.cell.2010.01.025. - DOI - PMC - PubMed
    1. Brandau S, Moses K, Lang S. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins? Semin Cancer Biol. 2013;23:171–182. doi: 10.1016/j.semcancer.2013.02.007. - DOI - PubMed

MeSH terms